+66.6%
VTV vs GSK
+47.2%
+19.5%
-14.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -1.0% | +0.4% | -0.5% |
| 7D | -2.1% | -5.4% | +3.4% | -1.2% |
| 30D | -1.3% | -4.6% | +3.3% | -0.6% |
| 3M | +5.6% | -5.1% | +10.7% | +6.4% |
| 6M | +12.4% | -11.4% | +23.8% | +14.3% |
| YTD | +17.6% | +0.7% | +16.9% | +17.2% |
| 1Y | +23.5% | +23.0% | +0.5% | +18.9% |
| All | +66.6% | +47.2% | +19.5% | +53.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling